Monday, October 15, 2018
 
 
Company News: Page (1) of 1 - 01/11/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
HedgePath Pharmaceuticals Secures New Funding from Mayne Pharma to Support BCCNS Clinical and Regulatory Approval Programs
HPPI receives three tranche preferred stock and warrant funding, with $2.4 million upfront, $1.6 million by mid-2018, and an additional $1 million by year end if BCCNS NDA is acceptedHPPI's Supply...
(January 11, 2018)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:USA, Inc.,Science,Communications Technology,Medical,Cancer,Business,Other,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Lee Health Selects GeBBS iCode Assurance SaaS Solution for HIM Auditing Workflow and Analytics
  • Global $6.87 Billion Contrast Agents/Media Market to 2025
  • Contrast Agents/Media Market, 2025
  • Global mHealth market is projected to attain a size of $132.2 billion by 2023
  • Biosurgery Market Analysis | Rising Investments in Healthcare and Expansions by Most Eminent Players Globally | Forecast 2023

    Cancer
  • Roche's Kadcyla reduced the risk of disease recurring in people with HER2-positive early breast cancer with residual disease after neoadjuvant treatment
  • InSight Telepsychiatry Presents First Annual Partner Awards
  • Internet Brands' WebMD Acquires prIME Oncology
  • Global Next Generation Sequencing Market: Whole Genome Sequencing is Growing at the Fastest CAGR | Emerging Trends & Strategy Analysis, by Key Players; Illumina, Inc., Qiagen, Agilent Technologies, Ge
  • Connected Health Conference 2018 Keynote Series: FCC Chairman Ajit Pai, Champion Of Rural Broadband And Telehealth
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines